From these, it is inferable that Keap1 and Keap1β may function as more potent tumour promoters, albeit both isoforms were endowed with an intrinsic capability to inhibit hyper-active Nrf2 at preventing tumour development and malgrowth. Here, NFE2L2 is linked to neoplasm.